Hong Kong IPO Surge: Five Companies Target $678M

Hong Kong's IPO pipeline gained momentum Friday as five companies filed for listings totaling HK$5.31 billion ($678 million). Despite global economic headwinds from the Middle East conflict, the city’s capital markets posted their strongest start since 2021.

Epiworld International, a Xiamen-based semiconductor materials firm specializing in silicon carbide wafers for EVs and renewables, leads with a HK$1.64 billion raise via 21.5 million H shares at HK$76.26 each.

Guangdong Huayan Robotics, producing collaborative robots for industrial and healthcare use, aims to secure HK$1.37 billion by offering 80.8 million H shares at HK$17.

Hangzhou Diagens Biotechnology, developing AI-driven medical imaging tools, seeks up to HK$899.9 million through 8 million H shares priced at HK$112.50.

Beijing Tong Ren Tang Healthcare Investment, a unit of state-owned traditional medicine giant Tong Ren Tang, plans to raise up to HK$897.7 million via 108.2 million H shares at HK$8.30.

Shandong Extreme Vision Technology, an AI firm, targets HK$499.2 million by issuing 12.5 million H shares at HK$40 apiece.